AstraZeneca | AZN - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
AbbVie USD 3.84B 205M 2026-09
Alcon AG USD 964M 82M 2026-06
Almirall -29.5M 4.72M 2026-06
Amgen USD 1.68B 40M 2026-09
argenx SE USD 598M 181M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Autolus Therapeutics Ltd USD 39.95M 4.16M 2026-03
Bayer EUR 4.02B 53M 2026-09
Biogen USD 752M 42.3M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Fresenius EUR 823M 63M 2026-09
Fresenius Medical Care EUR 744M 7.99M 2026-09
Genmab DKK 205M 39M 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
GRIFOLS EUR 326M 37M 2026-09
Haleon GBP 1.08B 11M 2025-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
Merck EUR 1.58B 11M 2026-09
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Orion EUR 98.9M 0 2026-09
Pfizer USD 3.28B 132M 2026-09
Philips EUR 1.17B 33M 2026-09
Recordati EUR 189.59M 12M 2026-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
UCB EUR 1.47B 193M 2025-12